Texas A.G. Paxton Investigates Potential Violations of State Law by Puberty-Blocking Drug Manufacturers
March 25, 2022
March 25, 2022
AUSTIN, Texas, March 25 -- Texas Attorney General Ken Paxton issued the following news release:
Texas Attorney General Ken Paxton has issued Civil Investigative Demands (CIDs) to AbbVie Inc. and Endo Pharmaceuticals, Inc. as part of an investigation to determine whether these manufacturers of puberty-blocking drugs deceptively advertised and promoted hormone blockers for unapproved uses without disclosing the potential risks to children and their parents. The CIDs follow an internal . . .
Texas Attorney General Ken Paxton has issued Civil Investigative Demands (CIDs) to AbbVie Inc. and Endo Pharmaceuticals, Inc. as part of an investigation to determine whether these manufacturers of puberty-blocking drugs deceptively advertised and promoted hormone blockers for unapproved uses without disclosing the potential risks to children and their parents. The CIDs follow an internal . . .